A detailed history of Fmr LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 902,136 shares of AXSM stock, worth $82.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
902,136
Previous 828,550 8.88%
Holding current value
$82.6 Million
Previous $66.1 Million 9.84%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$65.72 - $80.5 $4.84 Million - $5.92 Million
73,586 Added 8.88%
902,136 $72.6 Million
Q1 2024

May 13, 2024

SELL
$69.39 - $97.64 $3.71 Million - $5.22 Million
-53,477 Reduced 6.06%
828,550 $66.1 Million
Q4 2023

Feb 13, 2024

SELL
$57.42 - $83.61 $56.1 Million - $81.6 Million
-976,529 Reduced 52.54%
882,027 $70.2 Million
Q3 2023

Nov 13, 2023

SELL
$69.25 - $82.21 $18.7 Million - $22.2 Million
-270,410 Reduced 12.7%
1,858,556 $130 Million
Q2 2023

Aug 11, 2023

BUY
$58.41 - $90.35 $44.6 Million - $69 Million
764,012 Added 55.97%
2,128,966 $153 Million
Q1 2023

May 11, 2023

BUY
$58.39 - $75.0 $36.8 Million - $47.3 Million
630,517 Added 85.85%
1,364,954 $84.2 Million
Q4 2022

Feb 13, 2023

BUY
$39.94 - $79.72 $15.4 Million - $30.7 Million
385,541 Added 110.5%
734,437 $56.6 Million
Q3 2022

Nov 10, 2022

BUY
$36.06 - $69.85 $4.07 Million - $7.89 Million
112,905 Added 47.84%
348,896 $15.6 Million
Q2 2022

Aug 12, 2022

BUY
$21.74 - $46.75 $2.46 Million - $5.28 Million
112,971 Added 91.83%
235,991 $9.04 Million
Q1 2022

May 13, 2022

SELL
$23.7 - $41.39 $7.25 Million - $12.7 Million
-305,963 Reduced 71.32%
123,020 $5.09 Million
Q4 2021

Feb 14, 2022

BUY
$30.7 - $43.36 $173,178 - $244,593
5,641 Added 1.33%
428,983 $16.2 Million
Q3 2021

Nov 15, 2021

BUY
$19.91 - $68.26 $1.45 Million - $4.97 Million
72,807 Added 20.77%
423,342 $14 Million
Q2 2021

Aug 13, 2021

BUY
$50.63 - $73.5 $17.7 Million - $25.8 Million
350,535 New
350,535 $23.6 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.93B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.